GIL
Gildan Activewear Inc.
GIL trails on the overall score without a compensating advantage in the available component scores.
LCID
Lucid Group, Inc.
LCID has the edge over GIL overall, supported by stronger valuation and stronger modeled upside.
GIL Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Healthy | |
| Weak |
GIL's revenue, profitability and cash flow are currently healthy, but its balance sheet is weak.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
GIL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.2x | $34.83 | — |
| Cheap | 11x | $5.67 | -84% |
| Fair | 17x | $9.22 | -74% |
| Expensive | 24x | $12.73 | -63% |
| Current | 65x | $34.83 | — |
Historical ranges are pointers, not guarantees.
GIL's PE is in its expensive range at 65x. On analysts' estimates for next year's earnings, today's price would be 9.2x, in its cheap range.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
GIL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Decline | |
| Stable | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect GIL's earnings to decline, with its revenue and profitability holding steady.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
GIL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.78 | +599% |
| Q3 2025 | $3.13 | +24% |
| Q3 2024 | $2.52 | -3.8% |
| Q2 2024 | $2.43 | -11% |
| Q1 2024 | $2.96 | +10% |
| Q4 2023 | $3.04 | +4.1% |
| Q3 2023 | $2.62 | -22% |
| Q2 2023 | $2.73 | -21% |
| Q1 2023 | $2.69 | -20% |
GIL has the stronger earnings trend. Trailing diluted EPS is down 79% for GIL versus LCID down 224%.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
GIL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.5B | +68% |
| Q1 2026 | $1.2B | +64% |
| Q4 2025 | $1.1B | +33% |
| Q3 2025 | $910.6M | +2.2% |
| Q2 2025 | $918.5M | +6.5% |
| Q1 2025 | $711.7M | +2.3% |
| Q4 2024 | $821.5M | +5% |
| Q3 2024 | $891.1M | +2.4% |
GIL's revenue has grown year over year for nine quarters in a row: $1.5B last quarter, up 68% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 17% | -4.9 points |
| Q1 2026 | 5.1% | -13 points |
| Q4 2025 | 17% | -4.6 points |
| Q3 2025 | 21% | N/A |
| Q2 2025 | 22% | +0.1 points |
| Q1 2025 | 18% | +2.2 points |
| Q4 2024 | 22% | +6.7 points |
| Q3 2024 | 22% | +3.8 points |
GIL has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over GIL on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
GIL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $316.5M | +93% |
| Q1 2026 | -$309.9M | -$145.4M |
| Q4 2025 | $280.6M | +65% |
| Q3 2025 | $203.1M | +35% |
| Q2 2025 | $163.7M | +58% |
| Q1 2025 | -$164.5M | -$93.1M |
| Q4 2024 | $169.9M | -16% |
| Q3 2024 | $150.5M | -43% |
GIL has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
GIL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +18K shares |
| 1 year | +23% | +34.4M shares |
| 3 years | +4.1% | +7.3M shares |
| 5 years | -7% | -13.9M shares |
| Available history | -8.9% | -18M shares |
GIL has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $4.8M |
| Q1 2026 | $71.5M |
| Q4 2025 | $3.4M |
| Q3 2025 | $29.4M |
| Q2 2025 | $77.1M |
| Q1 2025 | $87.4M |
| Q4 2024 | $220.6M |
| Q3 2024 | $381.2M |
GIL spent $109M buying back its own shares over the past year, down 86% from the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
GIL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 6.4x | High |
| Q1 2026 | 7.5x | High |
| Q4 2025 | 6.1x | High |
| Q3 2025 | 2.2x | Moderate |
| Q3 2024 | 2.1x | Moderate |
| Q2 2024 | 1.8x | Healthy |
| Q1 2024 | 1.6x | Healthy |
| Q4 2023 | 1.4x | Healthy |
GIL's net debt is about 6.4 years of its operating earnings (EBITDA), up from 2.1 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
GIL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.2 | Oversold |
| Stochastic | 9.3 | Oversold |
GIL's weekly RSI is 26 (oversold) and its Stochastic is 9 (oversold).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
GIL PE vs Consumer Cyclical Sector
| Metric | GIL | Sector median | Relative |
|---|---|---|---|
| PE | 65x | 18x | 258% above |
| PE % | 96 | 47 | 49 pts above |
GIL is trading at 65x earnings, a 258% premium to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
GIL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.3 | 11% below |
| 20 week MA | $47.5 | 27% below |
| 50 week MA | $55.7 | 37% below |
| 100 week MA | $53.4 | 35% below |
| 200 week MA | $44.5 | 22% below |
GIL is in a downtrend: it's below all five of its weekly moving averages, and 22% below its 200-week average.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
GIL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.6 | $28.2 | -4.5% |
| 2021 | $28.2 | $40.8 | +44% |
| 2022 | $40.8 | $27.1 | -34% |
| 2023 | $27.1 | $33.1 | +22% |
| 2024 | $33.1 | $46.9 | +42% |
| 2025 | $46.9 | $63.6 | +36% |
| 2026 YTD | $63.6 | $34.8 | -45% |
GIL has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.